Nexalin Technology NXL
NASDAQ NXL
$4.85 -0.20 (-3.96%)
As of: Sep 10, 2026 · 3:47 PM EDT

Nexalin Technology (NXL) Shares Outstanding (2021 - 2026)

Nexalin Technology (NXL) posted Shares Outstanding (Entity) of $733457.0 for Q2 2026, up 6.91% on a QoQ basis from $686055.0 in Q1 2026, and up 26.33% year-over-year from $580598.0 in Q2 2025.

Analysis

Nexalin Technology (NXL) Shares Outstanding (2021 - 2026) Analysis & Trends

Nexalin Technology has reported Shares Outstanding (Entity) for 6 years, with the latest figure at $733457.0 in Q2 2026.

  • On a quarterly basis, Shares Outstanding (Entity) rose 26.33% year-over-year to $733457.0 in Q2 2026; TTM through Jun 2026 was $733457.0, a 26.33% increase from a year earlier, with the FY2025 full-year figure at $639545.0, up 108.19% from the prior year.
  • Shares Outstanding (Entity) was $733457.0 for Q2 2026 at Nexalin Technology, up from $686055.0 in the prior quarter.
  • The five-year high for Shares Outstanding (Entity) was $733457.0 in Q2 2026, with the low at $163505.0 in Q1 2022.
  • Average Shares Outstanding (Entity) over 5 years is $366339.3, with a median of $250385.0 recorded in 2023.
  • The sharpest annual moves came in 2024 and 2025: Shares Outstanding (Entity) rose 2.06% in 2024, then soared 129.59% in 2025.
  • Over 5 years, Shares Outstanding (Entity) stood at $185747.0 in 2022, then soared by 33.45% to $247885.0 in 2023, then rose by 23.93% to $307192.0 in 2024, then jumped by 108.19% to $639545.0 in 2025, then increased by 14.68% to $733457.0 in 2026.
  • The last three Shares Outstanding (Entity) figures came in at $733457.0 (Q2 2026), $686055.0 (Q1 2026), and $639545.0 (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Qtr)
1 Abbott Laboratories 179.84 Bn 174.23 Bn 7.27 Bn 1.74 Bn
2 Intuitive Surgical 128.02 Bn 122.81 Bn 1.96 Bn 354.10 Mn
3 Medtronic 117.28 Bn 108.46 Bn 6.34 Bn 1.28 Bn
4 Stryker 103.92 Bn 100.44 Bn 4.50 Bn 383.50 Mn
5 Boston Scientific 63.51 Bn 62.97 Bn 3.85 Bn 1.47 Bn
6 Edwards Lifesciences 49.96 Bn 45.70 Bn 1.35 Bn 576.40 Mn
7 Alcon 32.86 Bn 31.40 Bn 1.68 Bn 493.20 Mn
8 Dexcom 32.25 Bn 30.30 Bn 830.00 Mn 382.20 Mn
9 Steris 20.74 Bn 20.26 Bn 684.20 Mn 97.60 Mn
10 Nexalin Technology 3.42 Mn 2.41 Mn 8,897.00 704,764.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 704,764.00
Mar 31, 2026 660,697.00
Dec 31, 2025 546,416.00
Sep 30, 2025 593,128.00
Jun 30, 2025 523,938.00
Mar 31, 2025 443,577.00
Dec 31, 2024 307,192.00
Sep 30, 2024 361,583.00
Jun 30, 2024 249,918.00
Mar 31, 2024 247,885.00
Dec 31, 2023 245,234.00
Sep 30, 2023 247,179.00
Jun 30, 2023 242,885.00
Mar 31, 2023 242,885.00
Dec 31, 2022 185,747.00
Sep 30, 2022 172,890.00
Jun 30, 2022 163,224.00
Mar 31, 2022 162,936.00
Dec 31, 2021 141,879.00
Sep 30, 2021 147,452.00